Ruthnea Aparecida Lazaro Muzzi

Prof. Dr. Ruthnea Aparecida Lazaro Muzzi

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Journal of Veterinary Cardiology
Verified
Journal Article
Closed access
JSJulia Sargent
Julia Sargent
Ruthnea Aparecida Lazaro MuzziRuthnea Aparecida Lazaro Muzzi
Ruthnea Aparecida Lazaro Muzzi
RMRajat Mukherjee
Rajat Mukherjee
SSSharlene Somarathne
Sharlene Somarathne
KSKatherine Schranz
Katherine Schranz
VFVirginia Luis Fuentes
Virginia Luis Fuentes

1 November 2003 in Journal of Veterinary Cardiology
Verified
Journal Article
Closed access
Ruthnea Aparecida Lazaro MuzziRuthnea Aparecida Lazaro Muzzi
Ruthnea Aparecida Lazaro Muzzi
RARoberto B de Araújo
Roberto B de Araújo
LMLeonardo AL Muzzi
Leonardo AL Muzzi
JPJosé Lb Pena
José Lb Pena
ESEuler Fraga Silva
Euler Fraga Silva

1 January 2006 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
Ruthnea Aparecida Lazaro MuzziRuthnea Aparecida Lazaro Muzzi
Ruthnea Aparecida Lazaro Muzzi
LMLeonardo Augusto Lopes Muzzi
Leonardo Augusto Lopes Muzzi
RARoberto Baracat de Araújo
Roberto Baracat de Araújo
MCMarcos Cherem
Marcos Cherem
Muzzi RA, et al. J Vet Sci. 2006 Jun;7(2):193-198. https://doi.org/10.4142/jvs.2006.7.2.193

30 October 2014 in Journal of Feline Medicine and Surgery
Verified
Journal Article
Closed access
IMImke März
Imke März
LWLois J Wilkie
Lois J Wilkie
NHNorelene Harrington
Norelene Harrington
JPJessie R Payne
Jessie R Payne
Ruthnea Aparecida Lazaro MuzziRuthnea Aparecida Lazaro Muzzi
Ruthnea Aparecida Lazaro Muzzi
VFVirginia Luis Fuentes
Virginia Luis Fuentes
Norwegian Forest cats (NFCs) are often listed as a breed predisposed to cardiomyopathy, but the characteristics of cardiomyopathy in this breed have not been described. The aim of this preliminary study was to report the features of NFC cardiomyopathy based on prospective echocardiographic screening of affected family groups; necropsy findings; and open-source breed screening databases. Prospective examination of 53 NFCs revealed no murmur or left ventricular (LV) outflow tract obstruction in any screened cat, though mild LV hypertrophy (defined as diastolic LV wall thickness ≥5.5mm) was present in 13/53 cats (25%). Gross pathology results and histopathological sections were analysed in eight NFCs, six of which had died of a cardiac cause. Myocyte hypertrophy, myofibre disarray and interstitial fibrosis typical of hypertrophic cardiomyopathy were present in 7/8 cats, but endomyocardial fibrosis suggestive of restrictive cardiomyopathy was also present in the same cats. Pedigree data analysis from 871 NFCs was supportive of a familial cardiomyopathy in this breed.

16 June 2012 in Veterinary Record
Verified
Journal Article
Open access
PDF file
MOM. S. Oliveira
M. S. Oliveira
Ruthnea Aparecida Lazaro MuzziRuthnea Aparecida Lazaro Muzzi
Ruthnea Aparecida Lazaro Muzzi
RAR. B. Araújo
R. B. Araújo
LML. A. L. Muzzi
L. A. L. Muzzi
Daniel FerreiraDaniel Ferreira
Daniel Ferreira
ESE. F. Silva
E. F. Silva
Time‐domain heart rate variability (HRV) parameters and the correlation between echocardiography and Holter examinations in dogs with myxomatous mitral valve disease (MMVD) were determined. Holter examination was also performed at different time frames: an entire 24‐hour period, a four‐hour period during sleep, and a four‐hour period while awake. Ten healthy (control group) and 28 MMVD dogs, 15 with and 13 without heart failure, were evaluated. The SDANN (sd of the mean normal RR intervals for all five‐minute segments during 24‐hour Holter) and pNN 50 (percentage of differences between adjacent normal RR intervals that are >50 ms computed over 24‐hour Holter) variables were significantly lower in the dogs with MMVD heart failure. The differences in HRV between the groups were only detected during the 24‐hour evaluation period (P < 0.05). There were high correlations (canonical analysis) between Holter and echocardiography examinations when considering pNN 50 , SDANN, and LA/AO (left atrial to aortic root ratio) (r = 0.92; P < 0.05), indicating that both are important in evaluating MMVD dogs. SDANN and pNN 50 are measures of parasympathetic control of the heart, and thus, it is possible to infer that the MMVD dogs exhibit parasympathetic withdrawal during the development of heart failure.

1 April 2014 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
PDF file
MOM.S. Oliveira
M.S. Oliveira
Ruthnea Aparecida Lazaro MuzziRuthnea Aparecida Lazaro Muzzi
Ruthnea Aparecida Lazaro Muzzi
RAR.B. Araújo
R.B. Araújo
LML.A.L. Muzzi
L.A.L. Muzzi
Daniel FerreiraDaniel Ferreira
Daniel Ferreira
ESE.F. Silva
E.F. Silva
Cardiac diseases promote alterations in the autonomic control of the heart, leading to an increase in heart rate and, as a result, a decrease in heart rate variability (HRV).The aim of this study was to evaluate if the development of heart failure secondary to degenerative mitral valve disease (DMVD) concurs with changes in autonomic modulation of heart rhythm which are assessed by long electrocardiography examination (Holter). Dogs were evaluated by clinical examination and echocardiography in order to be categorized into the following groups: Control (healthy; n=6), DMVD (disease without heart failure; n=8), and DMVD heart failure (disease with heart failure; n=13). Arrhythmias and frequency domain HRV were determined by Holter. Diseased animals, when compared to healthy, had significantly lower total power, which indicates overall HRV. DMVD heart failure dogs also showed other disturbances such as high incidence of supraventricular arrhythmias, high heart rate, little amount of pauses (2.0s long between consecutive heartbeats), longer time in tachycardia, shorter time in bradycardia, low high frequency (parasympathetic control), and high low frequency (sympathetic and parasympathetic control) when compared to control (p<0.05). In DMVD dogs, Holter-derived variables changed with the development of heart failure.